학술논문
Validation of an administrative coding algorithm for the identification of individuals with amyloid light chain amyloidosis using administrative data.
Document Type
Article
Author
Source
Subject
*AMYLOIDOSIS
*CARDIAC amyloidosis
*AMYLOID
*IMMUNOGLOBULIN light chains
*ALGORITHMS
*
*
*
*
Language
ISSN
1042-8194
Abstract
Amyloid light chain (AL) amyloidosis is a rare plasma cell disease in which AL protein deposits form throughout the body, with the heart, and kidney being the most commonly affected organs [[1]]. Quock et al. previously developed an algorithm for AL amyloidosis whereby individuals with general amyloidosis ICD codes were flagged as having AL amyloidosis if they received one or more guideline concordant therapies [[3]]. Individuals were flagged as having AL amyloidosis if they had one inpatient or two outpatient amyloidosis ICD codes and had received any one of the following AL amyloidosis therapies on or after the date of the earliest amyloidosis ICD code: cyclophosphamide, carfilzomib, bortezomib, bendamustine, daratumumab, lenalidomide, melphalan, ixazomib, pomalidomide, and thalidomide. [Extracted from the article]